Company intelligence / Profile preview

DCN Dx

Carlsbad, California, United Statesdcndx.com ↗

Ownership: Private
Development stage: Other

Overview

Provides end-to-end contract development and manufacturing for point-of-use in vitro diagnostic assays with specialty in lateral flow tests. Offers regulatory support and clinical research services. No proprietary therapeutic or diagnostic pipeline; operates as a service provider.

No clinical trial results reported—focuses on enabling clients' products.

Recent innovations include the miniDxR reader for high-performance lateral flow assays.

Therapeutic areas: OncologyOther
Modalities: DeviceProtein (antibodies, conjugates)Reagent kitLateral flow assay technology
Industry: Contract Manufacturing Organization

Partnerships

Not specifically disclosed.

Beyond the preview

Go deeper on DCN Dx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DCN Dx.

Explore the full profile